- Home
- PWOD vs CRVS Comparison
PWOD vs CRVS Comparison
Compare PWOD & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWOD
- CRVS
- Stock Information
- Founded
- PWOD 1934
- CRVS 2014
- Country
- PWOD United States
- CRVS United States
- Employees
- PWOD N/A
- CRVS N/A
- Industry
- PWOD Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- PWOD Finance
- CRVS Health Care
- Exchange
- PWOD Nasdaq
- CRVS Nasdaq
- Market Cap
- PWOD 231.2M
- CRVS 305.4M
- IPO Year
- PWOD N/A
- CRVS 2016
- Fundamental
- Price
- PWOD $31.41
- CRVS $4.17
- Analyst Decision
- PWOD
- CRVS Strong Buy
- Analyst Count
- PWOD 0
- CRVS 4
- Target Price
- PWOD N/A
- CRVS $15.00
- AVG Volume (30 Days)
- PWOD 75.5K
- CRVS 1.0M
- Earning Date
- PWOD 07-24-2025
- CRVS 08-05-2025
- Dividend Yield
- PWOD 3.97%
- CRVS N/A
- EPS Growth
- PWOD 28.19
- CRVS N/A
- EPS
- PWOD 2.80
- CRVS N/A
- Revenue
- PWOD $74,314,000.00
- CRVS N/A
- Revenue This Year
- PWOD N/A
- CRVS N/A
- Revenue Next Year
- PWOD N/A
- CRVS N/A
- P/E Ratio
- PWOD $11.53
- CRVS N/A
- Revenue Growth
- PWOD 16.68
- CRVS N/A
- 52 Week Low
- PWOD $20.18
- CRVS $1.96
- 52 Week High
- PWOD $34.56
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- PWOD 56.84
- CRVS 53.38
- Support Level
- PWOD $31.73
- CRVS $4.08
- Resistance Level
- PWOD $32.46
- CRVS $4.31
- Average True Range (ATR)
- PWOD 0.64
- CRVS 0.25
- MACD
- PWOD 0.06
- CRVS 0.01
- Stochastic Oscillator
- PWOD 62.07
- CRVS 68.66
About PWOD Penns Woods Bancorp Inc.
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).